Enter query terms separated by spaces.

Search for:
Display results by:
Search from:
 
through:
 

U.S. Company Warned on Anthrax Claims From Monday, November 28, 2005 issue.

U.S. Company Warned on Anthrax Claims


The U.S. Food and Drug Administration has warned a company to stop making claims that its products protect against anthrax, the Dallas Morning News reported (see GSN, Aug. 24).

Bio-Germ Protection has been marketing its cream and aerosol spray as a way to protect against anthrax infection. The products have been endorsed by a law-enforcement official, a congressman and an academic, according to the Morning News.

Representative Ralph Hall (R-Texas), the lawmaker who endorsed the products, also arranged a meeting between Bio-Germ founder Allen Lord and the head of the U.S. Health and Human Services Department, the Morning News reported.

Robert Heiman, developer of the products, said he warned Lord about making the claims. “I’ve been advising Allan to take those statements off [the Web site] for almost a year,” he said.

Heiman added that the administration’s warning does not mean the products do not have the potential to counter anthrax. 

“We’re getting some incredible results, and we’re doing some very extensive research, and I have no problem working with the FDA,” Heiman said. “This is good, solid science.  What happened is Allan just jumped the gun.”

The agency, in the warning sent to Bio-Germ last month, said that the company must immediately stop saying that its products could treat anthrax, plague and other “pathogens possibly used by terrorists.”

You must immediately correct these violations,” the warning letter said. “If you do not immediately correct them, you may be subject to enforcement action without further notice.”

Bio-Germ subsequently removed the cream and spray from its Web site, according to the Morning News (Michael Grabell, Dallas Morning News, Nov. 25).


Back to top
   

 

About Newswire  |  Contact National Journal  |  Re-Use Guidelines

© Copyright 2008 by National Journal Group, Inc. The material in this section is produced independently for NTI by National Journal Group, Inc. Any reproduction or retransmission, in whole or in part, is a violation of federal law and is strictly prohibited without the consent of the National Journal Group, Inc. All rights reserved.